View by Year:
Defining a molecular phenotype for benign and malignant parathyroid tumors.
Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers.
Surgery, Dec-2008;144(6):908-13; discussion 913-4.
Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling.
Archives of surgery (Chicago, Ill. : 1960), Sep-2008;143(9):841-6; discussion 846.
Candidate diagnostic markers and tumor suppressor genes for adrenocortical carcinoma by expression profile of genes on chromosome 11q13.
World journal of surgery, May-2008;32(5):873-81.
The prevalence and prognostic value of BRAF mutation in thyroid cancer.
Annals of surgery, Sep-2007;246(3):466-70; discussion 470-1.
Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.
Endocrine-related cancer, Dec-2006;13(4):1173-83.
Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms.
World journal of surgery, May-2006;30(5):767-74.
Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells.
Surgery, Dec-2005;138(6):979-84; discussion 984-5.
Variable expression of coxsackie-adenovirus receptor in thyroid tumors: implications for adenoviral gene therapy.
Thyroid : official journal of the American Thyroid Association, Sep-2005;15(9):977-87.